4//SEC Filing
Poirier Michael S. 4
Accession 0001493152-22-017505
CIK 0001460702other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:55 PM ET
Size
14.0 KB
Accession
0001493152-22-017505
Insider Transaction Report
Form 4
Poirier Michael S.
DirectorChairman, President & CEO.
Transactions
- Purchase
Common Stock
2022-06-22$0.57/sh+30,000$17,100→ 199,202 total
Holdings
- 11,005(indirect: By IRA)
Common Stock
Documents
Issuer
Qualigen Therapeutics, Inc.
CIK 0001460702
Entity typeother
Related Parties
1- filerCIK 0001812504
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:55 PM ET
- Size
- 14.0 KB